Category Specific RSS

News

Immuron enrols first patients into Phase 2 trials for treatment to combat infectious diarrhea

Infectious diarrhea could soon be not so infectious with confirmation from biotech company Immuron (ASX: IMC) that the first patients…

3 years ago

Are we in the eye of the inflation storm? | Economic update

During November the market consensus shifted towards the FOMC and ECB remaining on hold throughout 2024. This reflects a forecast…

3 years ago

Fragrances to treat allergies? Microba and IFF enter stage two of novel treatments

Precision microbiome company Microba (ASX: MAP) and the US-based F&B company International Flavors & Fragrances (IFF) have entered the second…

3 years ago

RAS Technology dives deeper into European wagering with Playbook Engineering partnership

Quickly becoming the go-to supplier of critical data within the global wagering industry, RAS Technology (ASX: RTH) has been engaged…

3 years ago

BluGlass signs $2.6 million contract with North Carolina State Uni to develop lasers

After becoming a member of the US CLAWS hub in October 2023, semiconductor developer BluGlass (ASX: BLG) has signed its…

3 years ago

Amid debt dispute, Electro Optic Systems reports revenue guidance of $210 to $230 million

In the midst of a debt dispute with a major lender, Australian security technology company Electro Optic Systems (ASX: EOS),…

3 years ago

Use your mobile to check for arrhythmia as Advanced Health Intelligence launches AF-Scan

HealthTech company Advanced Health Intelligence (ASX: AHI) is set to launch a medically-approved mobile phone-based atrial fibrillation (AF) assessment in…

3 years ago

The Calmer Co reports monthly record of eCommerce kava sales thanks to Black Friday

Derived from the roots of the Piper methysticum plant native to the Pacific Islands, Kava has gained popularity for its…

3 years ago

Little Green Pharma has big news: a new CEO and 37% revenue growth

Over the years, the Australian cannabis market has consistently posted revenue growth and is expected to be valued at $1.1…

3 years ago

The BESS-T bet: GenusPlus and Samsung joint venture awarded $200m to build energy solution

National power and communications infrastructure provider GenusPlus (ASX: GNP) has secured three contracts in collaboration with Samsung C&T Corporation. These…

3 years ago